Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot?

Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?

And here is our regular feature in which we highlight a different person each week. This time around, we note that BeiGene hired Dr. Ji Li as executive vice president, global head of business development. Previously, he was vice president of business development and licensing at Merck Research Laboratories. Before that, he was executive licensing director, external R&D at Amgen.


Biogen said that Adam Koppel is resigning as executive VP, strategy and business development;

Mylan hired Kenneth Parks as chief financial officer;


Novartis says that Eric Cornut is retiring as chief ethics and compliance officer;

Novartis named Shannon Klinger as chief ethics and compliance officer;

Faron Pharmaceuticals hired Dr. Matti Karvonen as medical director;

Nurix promoted Pierre Beaurang to chief business officer;

Nurix named Hans van Houte as vice president of finance;

PharmaCyte Biotech hired Sanjay Batra as senior business development advisor;

Abeona Therapeutics hired Christine Silverstein as vice president, investor relations;

Ivenix hired Susan Niemeier as chief nursing officer;

Bicycle Therapeutics hired Michael Skynner as vice president of operations;

Bicycle Therapeutics hired Alan Watt as vice president of therapeutics;

Bicycle Therapeutics hired Gillian Langford as head of clinical and project management;

Blue Cross Blue Shield of Massachusetts hired Dr. Bruce Nash as chief physician executive.